Patrick Newingham - Founder, CEO

Patrick Newingham is a clinical supply and research professional with more than 25 years of experience leading global clinical supply chains across biotechnology, pharmaceutical, and vendor organizations. He is driven by a clear purpose: ensuring that life-saving therapies reach patients efficiently, reliably, and at scale.

Throughout his career, Patrick has worked across the full spectrum of clinical supply operations—from early-stage biotech environments to large multinational pharmaceutical companies —and has led clinical supply functions within vendor organizations supporting drug development partnerships. This breadth of experience gives him a uniquely comprehensive perspective on optimizing supply chains in complex, global clinical trials.

In his current role, Patrick leads initiatives across all aspects of clinical supply management, focusing on streamlining operations, improving forecasting, and strengthening end-to-end supply chain performance. His work is centered on reducing complexity while increasing reliability, ultimately accelerating the delivery of critical medicines to patients worldwide.

Over the past decade, he has built deep expertise in clinical supply strategy and execution. At Novavax, Patrick spearheaded operational improvements that increased on-time delivery to clinical trial sites by 20% while significantly reducing material waste. These results reinforced his belief that operational excellence is directly tied to both patient outcomes and trial success.

Previously, at AstraZeneca, Patrick directed the supply of clinical trial materials for more than 100 global studies. He ensured strict compliance with GCP and GMP standards while strengthening budget performance through disciplined forecasting and strategic planning.

Earlier in his career, Patrick led the clinical supplies group at Chiron, supporting the development of vaccines, immunology, and oncology products. During the 2004 global flu vaccine shortage, he played a key role in ensuring supply continuity under significant time and resource constraints. He also led a clinical labeling and distribution organization at Dow Pharmaceutical Sciences, where he gained valuable vendor-side experience—managing GMP inspections, overseeing production and warehouse operations, negotiating client contracts, and driving cost efficiencies through improved processes.

Patrick began his career at Immunex, contributing to the development and launch of a successful rheumatoid arthritis therapy, and at Cell Therapeutics, Inc., where he supported oncology research in a laboratory setting.

He is passionate about collaboration and continuous improvement, always seeking opportunities to share knowledge, learn from others, and develop innovative solutions that optimize clinical supply chains and enable successful trials.

Outside of his professional work, Patrick is deeply committed to community and environmental impact. He volunteers in community health initiatives and partners with organizations supporting K–12 education in African countries. In his personal time, he enjoys hiking, scuba diving, coral restoration, and cycling—activities that keep him connected to both people and the environment, and reinforce his dedication to improving global health.